1. From the Third Department of Internal Medicine (S.T., K.F., N.K., Y.K.), University of the Ryukyus School of Medicine, Okinawa; the First Department of Internal Medicine (T.E.), Miyazaki Medical College, Miyazaki; the Second Department of Internal Medicine (Y.T.), Faculty of Medicine, Kyushu University, Fukuoka; the Research Laboratory (T.T.), Yoshitomi Pharmaceutical Industries, Ltd, Fukuoka; Seiwa Experimental Animals, Ltd (K.O.), Fukuoka; and the National Cardiovascular Center (S.T.), Osaka, Japan.